
Welcome back to another edition of Mounjaro updates, industry news, alliteration, and my patently impertinent opinions. Each week, I reveal my experiences with GLP-1 receptor agonist therapy for Type 2 diabetes. At age 78, I've been at it for almost … [Continue reading]